Covid-19 Vaccine: Made In India Covaxin Up To 81% Effective, Claims Trial
According to the statement by the company, the trials revealed that ¡° the vaccine candidate was well tolerated.¡±
Made in India vaccine Covaxin by Bharat Biotech for the novel coronavirus has shown an interim efficacy of around 81 percent in late-stage clinical trials, in individuals who didn't have a prior infection, the company announced on Wednesday, March 3, 2021.
Reuters
Reported first by Reuters, the Covaxin vaccine trial that delivered this result involved around 25,800 participants, and was done in collaboration with the Indian government¡¯s medical research body.
According to the trials, thirty-six of the 43 cases were recorded in participants who received a placebo, compared with seven cases in people who were given the Bharat Biotech vaccine, pointing to an efficacy rate of 80.6%, the company said. According to the statement by the company, the trials revealed that ¡° the vaccine candidate was well tolerated.¡±
ALSO READ: CoWin And Maps: How To Find COVID-19 Vaccination Centres Near You
This comes at a time when the government has announced vaccination of people who are over 60 years of age as well as people of over 45 with comorbidities.
This is one of the two vaccines that were permitted for emergency use, by the Drug Controller General of India (DCGI) in January , 2021. Covaxin was, at the time, surrounded by concerns since there wasn¡¯t enough data available (the vaccinations had commenced without late-stage efficacy data) to claim its effectiveness and safety for mass vaccinations.
To instil faith in Indians, Prime Minister Narendra Modi got himself vaccinated with Bharat-Biotech¡¯s Covaxin at Delhi¡¯s AIIMS hospital. He was also one of the first individuals in India to get vaccinated upon commencement of Phase II of vaccination.
Reuters
More effective than Oxford-Astrazeneca vaccine
Surprisingly, the effectiveness of the made in India vaccine, Covaxin is around 13.6 percent more than that of the Oxford-AstraZeneca vaccine that is known in India as Covishied (Covishield is 67 percent effective), and has been authorised by the aforementioned pharmaceutical giant to be manufactured by Serum Institute of India, in Pune, Maharashtra.
What do you think about this interim efficacy report of Bharat Biotech's Covaxin vaccine trail results? Let us know in the comments section below...
